Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 1 of the 24 sources its claims cite were checked for support.
Abstract
Epigenetic modifiers have fundamental roles in defining unique cellular identity through the establishment and maintenance of lineage-specific chromatin and methylation status. Several DNA modifications such as 5-hydroxymethylcytosine (5hmC) are catalysed by the ten eleven translocation (Tet) methylcytosine dioxygenase family members, and the roles of Tet proteins in regulating chromatin architecture and gene transcription independently of DNA methylation have been gradually uncovered. However, the regulation of immunity and inflammation by Tet proteins independent of their role in modulating DNA methylation remains largely unknown. Here we show that Tet2 selectively mediates active repression of interleukin-6 (IL-6) transcription during inflammation resolution in innate myeloid cells, including dendritic cells and macrophages. Loss of Tet2 resulted in the upregulation of several inflammatory mediators, including IL-6, at late phase during the response to lipopolysaccharide challenge. Tet2-deficient mice were more susceptible to endotoxin shock and dextran-sulfate-sodium-induced colitis, displaying a more severe inflammatory phenotype and increased IL-6 production compared to wild-type mice. IκBζ, an IL-6-specific transcription factor, mediated specific targeting of Tet2 to the Il6 promoter, further indicating opposite regulatory roles of IκBζ at initial and resolution phases of inflammation. For the repression mechanism, independent of DNA methylation and hydroxymethylation, Tet2 recruited Hdac2 and repressed transcription of Il6 via histone deacetylation. We provide mechanistic evidence for the gene-specific transcription repression activity of Tet2 via histone deacetylation and for the prevention of constant transcription activation at the chromatin level for resolving inflammation.
Overview
CoChat Summary
TL;DR
Tet2 actively represses Il6 transcription during the late phase of LPS-driven inflammation in myeloid cells by recruiting Hdac2 to the Il6 promoter, independent of DNA methylation. Tet2 loss prolongs IL-6 production and worsens endotoxin shock and DSS-induced colitis in mice.
Key findings
- In Tet2-deficient or Tet2-silenced dendritic cells and macrophages, the early LPS-induced rise in Il6 mRNA before 4 h was largely unchanged, but after 8 h Il6 mRNA remained elevated while control cells declined; IL-6 protein also increased, whereas Tnfa levels were similar. Tet3 silencing barely affected Il6.
- Tet2-deficient mice produced more IL-6 after systemic LPS, especially late, and showed worse lung tissue damage; in DSS colitis they had greater weight loss, higher IL-6, more inflammatory cell infiltration, and mucosal disruption. In Tet2-deficient BMDC, 22 genes were downregulated and 13 upregulated; 12 of the upregulated genes were TLR-induced, including Il6.
- IκBζ interacted with Tet2 and was required for Tet2 binding to the Il6 promoter at late LPS phase. IκBζ overexpression increased Il6 early but reduced it late, and Tet2 loss impaired this late repression.
- Tet2 associated with Hdac1/Hdac2 through its core-DSBH domain. Hdac2 binding at the Il6 promoter fell early and returned late; Hdac2 knockdown increased Il6 transcription and histone acetylation at 10 h, with Hdac1 compensation by 12 h. Catalytically mutant Tet2 still repressed Il6, and Tet2 loss reduced Hdac2 binding and late histone deacetylation.
Methods
- Mouse models included C57BL/6, Tet2fl/fl, Tet2-deficient, and Lyz2-Cre myeloid-specific Tet2-deficient mice; human monocytes came from healthy donors. Cells studied included BMDC, BMM, peritoneal macrophages, and splenic T, B, and NK cells, with LPS at 100 ng/ml; in vivo models were endotoxin shock and DSS colitis.
- Assays included RNA-seq, qPCR, ELISA, immunoblot, immunoprecipitation, co-IP with LC-MS/MS, ChIP and re-ChIP, luciferase reporters, siRNA knockdown, overexpression, and a GAL4-based recruitment assay.
- Statistics used unpaired Student’s t-tests with *P < 0.05 and P < 0.01; error bars were s.e.m. or s.d.; data were from triplicate technical or biological replicates and representative of three independent experiments.
Limitations
- The paper states that animal studies did not randomize by weight or sex and did not use blinding, and that sample size was not predetermined by a statistical method. It also states that HEK293T cells were not authenticated or tested for mycoplasma.
- Evident from the text: Hdac2 knockdown effects were transient because Hdac1 appeared to compensate by 12 h, complicating conclusions about Hdac2-specific repression.
- Evident from the text: many mechanistic experiments relied on overexpression or siRNA in HEK293T or primary cells, and the in vivo work used two inflammatory models; the authors note that additional Tet2-repressed mediators may exist in tissue-resident immune cells.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 16 Not checked · 86 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“MS-275 strongly inhibits Hdac1/2 over Hdac3 (ref. 19)”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Abstract
What the sources say
- Supportedcites [19] Inoue S Mai A Dyer MJ Cohen GM Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 2006 66 6785 6792 16818655 source
In the Results section 'Expression of HDACs in CLL cells and various cell lines', our copy reports that MS-275 (1-2.5 micromol/L) inhibited HDAC1 and HDAC2 activities by ~50-70% whereas 1 micromol/L did not inhibit HDAC3 (~20% only at 2.5 micromol/L), and explicitly frames the experiment as confirming that 'MS-275 was selectively inhibiting HDAC1 and HDAC2 rather than HDAC3'. The same section also states MS-275 preferentially inhibits HDAC1 (IC50 ~0.3 micromol/L) versus HDAC3 (IC50 ~8 micromol/L), though that IC50 comparison is itself credited to ref. 32; the paper's own immunoprecipitation/activity data carry the claim. Thus the paraphrase 'strongly inhibits Hdac1/2 over Hdac3' matches what this source attributes to MS-275. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“overexpressed Tet2 recruited more endogenous Hdac2 to the Il6 promoter”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Attenuated histone deacetylation in Tet2-deficient cells was also observed at late phase during LPS response”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“loss of Tet2 caused higher expression of IFN-γ in activated CD8+ T cells”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Loss of Tet2 barely affects TLR4 signalling pathways”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Extended Data
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
45 more claims
Create a free account to see all 103 claims and to verify the 15 references still open.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 28
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“mice deficient in Tet2 developed more severe inflammation in several tissues upon challenge with bacterial endotoxin”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [91]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“this effect on Il6 expression was independent of the catalytic function of Tet2”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [91]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“loss of TET2, an enzyme that catalyzes DNA demethylation, results in prolonged and high expression of proinflammatory cytokines, including IL-6 [180].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [180]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As CHIP-associated mutations are known to alter the development and function of myeloid cells”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results contrast with findings in peripheral macrophages after intraperitoneal injection in vivo (Zhang et al., 2015).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Zhang et al., 2015
Experimental — accuracy not yet measured
20 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Ito, S., D’Alessio, A. C., Taranova, O. V., Hong, K., Sowers, L. C., & Zhang, Y. (2010) · Nature · doi:10.1038/nature09303 · Cited by 2,373
TET enzymes, TDG and the dynamics of DNA demethylation
Kohli, R. M., & Zhang, Y. (2013) · Nature · doi:10.1038/nature12750 · Cited by 1,623
Suppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563
Gene-specific control of inflammation by TLR-induced chromatin modifications
Foster, S. L., Hargreaves, D. C., & Medzhitov, R. (2007) · Nature · doi:10.1038/nature05836 · Cited by 1,344
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M. E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.001 · Cited by 1,339
Self-citationImpaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Ko, M., Huang, Y., Jankowska, A. M., Pape, U. J., Tahiliani, M., Bandukwala, H. S., An, J., Lamperti, E. D., Koh, K. P., Ganetzky, R., et al. (2010) · Nature · doi:10.1038/nature09586 · Cited by 1,213
Distinct Effects of T-bet in T H 1 Lineage Commitment and IFN-γ Production in CD4 and CD8 T Cells
Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P., & Glimcher, L. H. (2002) · Science · doi:10.1126/science.1065543 · Cited by 1,172
Cited by
Items 201–300 of 797
Moreira, J. D., Koch, B. E. V., van Veen, S., Walburg, K. V., Vrieling, F., Guimarães, T. M. P. D., Meijer, A. H., Spaink, H. P., Ottenhoff, T. H. M., Haks, M. C., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00036 · Cited by 66
The Clinical Management of Clonal Hematopoiesis
Bolton, K. L., Zehir, A., Ptashkin, R. N., Patel, M. A., Gupta, D., Sidlow, R., Papaemmanuil, E., Berger, M. F., & Levine, R. L. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.11.006 · Cited by 64
Self-citationThe CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis
Müller, A., Dickmanns, A., Resch, C., Schäkel, K., Hailfinger, S., Dobbelstein, M., Schulze‐Osthoff, K., & Kramer, D. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134217 · Cited by 62
“It is assumed that IκBζ recruits epigenetic modifiers, such as TET2 or the SWI/SNF complex, to the promoter sites of its target genes, leading to a change in DNA methylation or nucleosome remodeling (11, 12).”
BackgroundClonal Hematopoiesis: From Mechanisms to Clinical Intervention
Köhnke, T., & Majeti, R. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0901 · Cited by 66
TET-Mediated Epigenetic Regulation in Immune Cell Development and Disease
Tsiouplis, N. J., Bailey, D. W., Chiou, L. F., Wissink, F. J., & Tsagaratou, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.623948 · Cited by 68
“However, simultaneous deletion of two or more TET proteins results in rapid, malignant transformation of a gamut of immune cell lineages (An et al., 2015; Zhao et al., 2015; Lio et al., 2016; Tsagaratou et al., 2017b).”
BackgroundYin, M., Yan, X., Weng, W., Yang, Y., Gao, R., Liu, M., Pan, C., Zhu, Q., Li, H., Wei, Q., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487027 · Cited by 58
KDM2B promotes IL-6 production and inflammatory responses through Brg1-mediated chromatin remodeling
Zhou, Q., Zhang, Y., Wang, B., Zhou, W., Bi, Y., Huai, W., Chen, X., Chen, Y., Liu, Z., Liu, X., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0251-z · Cited by 72
Øbro, N. F., Grinfeld, J., Belmonte, M., Irvine, M., Shepherd, M. S., Rao, T. N., Karow, A., Riedel, L. M., Harris, O. B., Baxter, E. J., et al. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000371 · Cited by 68
Dutta, D., & Lim, S. H. (2020) · Biomarker Research · doi:10.1186/s40364-020-00211-6 · Cited by 64
“and increased translocation of bacteria [32, 34].”
Postinfectious Epigenetic Immune Modifications — A Double-Edged Sword
DiNardo, A. R., Netea, M. G., & Musher, D. M. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2028358 · Cited by 67
USP38 Couples Histone Ubiquitination and Methylation via KDM5B to Resolve Inflammation
Zhao, Z., Su, Z., Liang, P., Liu, D., Yang, S., Wu, Y., Ma, L., Feng, J., Zhang, X., Wu, C., et al. (2020) · Advanced Science · doi:10.1002/advs.202002680 · Cited by 60
Self-citationThe central inflammatory regulator IκBζ: induction, regulation and physiological functions
Feng, Y., Chen, Z., Xu, Y., Han, Y., Jia, X., Wang, Z., Zhang, N., & Lv, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188253 · Cited by 66
“The mRNA level of IL-6 in I k B z -overexpressing macrophages was higher at the early stage but signi fi cantly decreased at the later stage in the LPS response (94).”
BackgroundSelf-citationEpigenetic Regulation of Neuroinflammation in Alzheimer’s Disease
Ma, Y., Wang, W., Liu, S., Qiao, X., Xing, Y., Zhou, Q., & Zhang, Z. (2023) · Cells · doi:10.3390/cells13010079 · Cited by 61
“Similarly, Tet2 deficiency in the hippocampus also leads to the initiation of inflammatory responses at an early stage, causing further aggravation of AD pathology and cognitive dysfunction particularly [80,81].”
BackgroundClonal hematopoiesis and hematological malignancy
Dunn, W. G., McLoughlin, M. A., & Vassiliou, G. S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180065 · Cited by 61
“Tet2 –/– mice also possess elevated IL-6 levels and reduced apoptosis in response to inflammatory cytokines (47, 56, 57), suggesting an additional feed-back loop through which TET2 mutations may drive CH. Reduced TET2 function is also implicated in IDH1-and IDH2-mutant CH. Located in the cytoplasm…”
Valentini, E., Zampieri, M., Malavolta, M., Bacalini, M. G., Calabrese, R., Guastafierro, T., Reale, A., Franceschi, C., Hervonen, A., Koller, B., et al. (2016) · Aging · doi:10.18632/aging.101022 · Cited by 55
“Nevertheless, the interesting TET2 up-regulation in PBMC, associated with ALT levels, could indicate the need of TET2 immunological functions [42] for orchestrating a specific immune response to liver insults.”
TET2 : A Novel Epigenetic Regulator and Potential Intervention Target for Atherosclerosis
Liu, Y., Peng, W., Qu, K., Lin, X., Zeng, Z., Chen, J., Wei, D., & Zuo, W. (2018) · DNA and Cell Biology · doi:10.1089/dna.2017.4118 · Cited by 64
“(independent of DNA methylation and hydroxymethylation) ASY Zhang et al. (2015) Bone marrow transplantation LDLR-/- chimeric mice with 10% of TET2deficient HSPCs / Inflammation (NLRP3 inflammasome-mediated IL-1b production) AS[ Fuster et al. (2017) AS, atherosclerosis; BMDC, bone marrow-derived dendritic cells; IL-6,…”
BackgroundInfluentialSelf-citationTET3 Inhibits Type I IFN Production Independent of DNA Demethylation
Xue, S., Liu, C., Sun, X., Li, W., Zhang, C., Zhou, X., Lu, Y., Xiao, J., Li, C., Xu, X., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.068 · Cited by 59
TET2: A cornerstone in normal and malignant hematopoiesis
Kunimoto, H., & Nakajima, H. (2020) · Cancer Science · doi:10.1111/cas.14688 · Cited by 61
Jiang, B., Ding, T., Guo, C., Bai, X., Cao, D., Wu, X., Sha, W., Jiang, M., Wu, L., & Gao, Y. (2022) · Advanced Science · doi:10.1002/advs.202201300 · Cited by 54
Hematopoietic Stem Cells and the Immune System in Development and Aging
Shevyrev, D., Tereshchenko, V., Berezina, T. N., & Александрович, Р. С. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065862 · Cited by 66
Somatic Mutations in Cardiovascular Disease
Heimlich, J. B., & Bick, A. G. (2022) · Circulation Research · doi:10.1161/circresaha.121.319809 · Cited by 59
Chen, X. '., Liu, X., Zhang, Y., Huai, W., Zhou, Q., Xu, S., Chen, X., Li, N., & Cao, X. (2018) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0170-4 · Cited by 55
Self-citationEpigenetic regulation of innate immune dynamics during inflammation
Caldwell, B. A., & Li, L. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae026 · Cited by 61
Atypical IκB proteins in immune cell differentiation and function
Annemann, M., Plaza-Sirvent, C., Schuster, M., Katsoulis-Dimitriou, K., Kliche, S., Schraven, B., & Schmitz, I. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.01.006 · Cited by 52
Niyongere, S., Lucas, N., Zhou, J.-M., Sansil, S. S., Pomicter, A. D., Balasis, M. E., Robinson, J., Kroeger, J. L., Zhang, Q., Zhao, Y. L., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0203-0 · Cited by 57
Self-citationCao, Y., Sun, Y., Chang, H., Sun, X., & Yang, S. (2019) · FEBS Letters · doi:10.1002/1873-3468.13583 · Cited by 51
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1
Saadatagah, S., Naderian, M., Uddin, M. M., Dikilitas, O., Niroula, A., Schuermans, A., Selvin, E., Hoogeveen, R. C., Matsushita, K., Nambi, V., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.0459 · Cited by 62
Self-citationHistone deacetylase 2 is essential for LPS ‐induced inflammatory responses in macrophages
Wu, C., Li, A., Hu, J., & Kang, J. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12203 · Cited by 57
“histone deacetylation.(34) However, in the current study, HDAC2 did not directly bind to the promoters of proinflammatory genes or regulate their transcription in response to LPS stimulation.”
BackgroundFlaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes
Banerjee, T., Calvi, L. M., Becker, M. W., & Liesveld, J. L. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.04.004 · Cited by 58
“TET2 has been associated with damping of inflammation and suppression of IL-6 effects [38].”
BackgroundLiu, J., Guo, B., Chen, Z., Wang, N., Iacovino, M., Cheng, J., Roden, C., Pan, W. Q., Khan, S. A., Chen, S., et al. (2017) · Blood · doi:10.1182/blood-2016-06-721027 · Cited by 51
Self-citationClonal haematopoiesis in cardiovascular disease: prognostic role and novel therapeutic target
Schuermans, A., & Honigberg, M. C. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01148-9 · Cited by 59
“29).”
The epigenetic hallmarks of immune cells in cancer
Yu, J. H., Xiao, C., Fan, T. T., Deng, Z., Wang, D., Cai, W., Li, J., Liao, T., Li, C., & He, J. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02255-4 · Cited by 61
Bauer, A. J., & Martin, K. A. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00019 · Cited by 53
“For example, during inflammation resolution, TET2 is recruited to Il-6 promoter by IκBζ in bone marrow-derived dendritic cells to repress IL-6 expression independent of TET2 enzymatic activity (86).”
BackgroundClonal hematopoiesis, aging, and cardiovascular diseases
Pardali, E., Dimmeler, S., Zeiher, A. M., & Rieger, M. A. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.006 · Cited by 52
The role of hydrogen sulphide signalling in macrophage activation
Sun, F., Luo, J., Yue, T., Wang, F., Yang, C., Zhang, S., Wang, X. Y., & Wang, C. (2020) · Immunology · doi:10.1111/imm.13253 · Cited by 48
Self-citationPhenylalanine diminishes M1 macrophage inflammation
Zhang, Q., Chen, S., Guo, Y., He, F., Fu, J., & Ren, W. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2296-0 · Cited by 48
“The replenishment of the TCA cycle intermediates downstream of citrate through increased carbon flux from glutamine (Jha et al., 2015) and glutamine-derived αke-toglutarate dampens the inflammatory response (Zhang et al., 2015).”
BackgroundSelf-citationSmeriglio, P., Grandi, F. C., Davala, S., Masarapu, V., Indelli, P. F., Goodman, S. B., & Bhutani, N. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax2332 · Cited by 47
“To exclude any systemic immune defects in the Tet1−/− mice, as observed in the Tet2−/− mice (54), we challenged mice with an acute infection by intraperitoneal lipopolysaccharide (LPS) injection.”
BackgroundMethodTet2 Inactivation Enhances the Antitumor Activity of Tumor-Infiltrating Lymphocytes
Lee, M., Li, J., Li, J., Fang, S., Zhang, J., Vo, A. T. T., Han, W., Zeng, H., Isgandarova, S., Martinez-Moczygemba, M., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3213 · Cited by 49
“In addition to changes in chromatin accessibility arising from Tet2 depletion in CD8þ TILs, Tet2 loss might abrogate its interaction with negative regulators of gene transcription, such as Sin3a (38) and Hdac2 (20), thereby contributing to augmented transcriptional activation in Tet2 deficient cells.”
BackgroundXu, C., Chen, Y., Zhang, H., Chen, Y., Shen, X., Shi, C., Liu, Y., & Yuan, W. (2016) · Scientific Reports · doi:10.1038/srep21580 · Cited by 56
Self-citationClonal Hematopoiesis and Its Impact on Cardiovascular Disease
Sano, S., Wang, Y., & Walsh, K. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0871 · Cited by 47
Vpr and Its Cellular Interaction Partners: R We There Yet?
Fábryová, H., & Strebel, K. (2019) · Cells · doi:10.3390/cells8111310 · Cited by 55
Clonal hematopoiesis and its emerging effects on cellular therapies
Bonin, M. V., Jambor, H. K., Teipel, R., Stölzel, F., Thiede, C., Damm, F., Kroschinsky, F., Schetelig, J., Chavakis, T., & Bornhäuser, M. (2021) · Leukemia · doi:10.1038/s41375-021-01337-8 · Cited by 60
Epigenetic Regulation: A Link between Inflammation and Carcinogenesis
Vezzani, B., Carinci, M., Previati, M., Giacovazzi, S., Sala, M. D., Gafà, R., Lanza, G., Wieckowski, M. R., Pinton, P., & Giorgi, C. (2022) · Cancers · doi:10.3390/cancers14051221 · Cited by 55
Mechanisms involved in hematopoietic stem cell aging
Fujino, T., Asada, S., Goyama, S., & Kitamura, T. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04356-5 · Cited by 56
“demonstrated that Tet2 recruits Hdac2 to deacetylate and downregulate IL-6 independent of the DNA hydroxymethylation mechanism [249].”
BackgroundXu, X., Wang, G., Ai, L., Shi, J., Zhang, J., & Chen, Y.-X. (2018) · Scientific Reports · doi:10.1038/s41598-018-34011-8 · Cited by 50
TET2 promotes anti‐tumor immunity by governing G‐MDSCs and CD8+ T‐cell numbers
Li, S., Feng, J., Wu, F., Cai, J., Zhang, X., Wang, H., Fetahu, I. S., Iwanicki, I. J., Ma, D., Hu, T., et al. (2020) · EMBO Reports · doi:10.15252/embr.201949425 · Cited by 53
“TET2 can inhibit the expression of IL-6 by recruiting HDAC2 in macrophages (Zhang et al , 2015).”
Self-citationWang, X., Li, H., Chen, S., He, J., Chen, W., Ding, Y., & Huang, J. (2021) · Immunology and Cell Biology · doi:10.1111/imcb.12455 · Cited by 47
“The methylcytosine dioxygenase Tet2 is induced by the activation of the inflammatory response in dendritic cells and macrophages and recruits HDAC2 to cooperatively suppress IL-6, leading to the resolution of inflammation.(44) We also observed potential inflammation resolution during M1 macrophage polarization.”
BackgroundZhang, Y., Gao, Y., Jiang, Y., Ding, Y., Chen, H., Yan, X. Y., Zhan, Z., & Liu, X. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01136-x · Cited by 52
“showed that despite of the general inhibitory role of TSA in pro-inflammatory gene transcription shortly after LPS stimulation, the mRNA of Il6 was enhanced during the late phase in the presence of TSA [67].”
BackgroundInfluentialNatural products for the treatment of ulcerative colitis: focus on the JAK/STAT pathway
Long, D., Mao, C., Zhang, W., Zhu, Y., & Xu, Y. Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1538302 · Cited by 49
The Atypical Inhibitor of NF-κB, IκBζ, Controls Macrophage Interleukin-10 Expression
Hörber, S., Hildebrand, D. G., Lieb, W. S., Lorscheid, S., Hailfinger, S., Schulze‐Osthoff, K., & Eßmann, F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.718825 · Cited by 46
Lian, H., Li, W., & Jin, W. (2016) · Oncotarget · doi:10.18632/oncotarget.11412 · Cited by 48
“com/oncotarget (OGT), the Sin 3A complex and hypoxiainducible factors (HIFs), independent of their enzymatic activity [12-16].”
BackgroundInfluentialReversing Post-Infectious Epigenetic-Mediated Immune Suppression
Abhimanyu, A., Ontiveros, C. O., Guerra-Resendez, R. S., Nishiguchi, T., Ladki, M., Hilton, I. B., Schlesinger, L. S., & DiNardo, A. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688132 · Cited by 47
“Acutely, tolerance is beneficial as studies have demonstrated that inhibiting postsepsis epigenetic-mediated immune suppression too early exacerbates immune pathology (14).”
BackgroundBurleson, J., Siniard, D. J., Yadagiri, V. K., Chen, X., Weirauch, M. T., Ruff, B. P., Brandt, E. B., Hershey, G. K. K., & Ji, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-43767-6 · Cited by 43
Diverse Epigenetic Regulations of Macrophages in Atherosclerosis
Yang, H., Sun, Y., Li, Q., Jin, F., & Dai, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.868788 · Cited by 53
“TET2 specifically represses IL-6 expression in macrophages, an event for inflammation resolution (48, 49).”
BackgroundThe many layers of epigenetic dysfunction in B-cell lymphomas
Jiang, Y., Domínguez, P. M., & Melnick, A. M. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000249 · Cited by 43
Kurian, J. R., Louis, S., Keen, K. L., Wolfe, A., Terasawa, E., & Levine, J. E. (2016) · Endocrinology · doi:10.1210/en.2016-1087 · Cited by 43
“Notably, Tet2 was recently found necessary for termination of NF B-initiated inflammatory gene expression in bone marrow-derived stem cells (36).”
BackgroundCai, Z., Lu, X., Zhang, C., Nelanuthala, S., Aguilera, F., Hadley, A., Ramdas, B., Fang, F., Nephew, K., Kotzin, J. J., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140707 · Cited by 42
Jin, F., Li, J., Guo, J., Doeppner, T. R., Hermann, D. M., Yao, G., & Dai, Y. (2021) · European Heart Journal Open · doi:10.1093/ehjopen/oeab022 · Cited by 41
“In macrophages, TET2 specifically represses the expression of IL-6 via recruiting HDAC2, an event required for inflammation resolution.(78,79) Partial reconstitution of bone marrow clonal haematopoiesis by transplanting TET2-mutant cells increases plaque size in Ldlr mice, in association with the production of IL-1b b…”
BackgroundThe Role of Inflammation in the Initiation and Progression of Myeloid Neoplasms
Balandrán, J. C., Lasry, A., & Aifantis, I. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0176 · Cited by 51
Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View
Sikking, M. A., Stroeks, S. L. V. M., Waring, O. J., Henkens, M. T. H. M., Riksen, N. P., Hoischen, A., Heymans, S. R. B., & Verdonschot, J. A. J. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030603 · Cited by 44
“50,78 However, in mice with ischemic HFrEF and a Jak2 V617F mutation, 12 JAK/STAT signaling increased over time, 54 leading to higher expression of IFN-γ and increased AIM2 inflammasome activity.”
Clonal haematopoiesis, ageing and kidney disease
Vlasschaert, C., Lanktree, M. B., Rauh, M. J., Kelly, T. N., & Natarajan, P. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00778-x · Cited by 43
“First, TET2 typically recruits HDACs to IL-6 and IL-1β promoter sites 39,46 ; TET2 truncating mutations impair HDAC-mediated repression of these gene targets 39 .”
Toll-like receptors in innate immunity and inflammation: from fundamental biology to clinic insights
Qian, C., Cao, X., & Hoffmann, J. A. (2026) · Immunity & Inflammation · doi:10.1007/s44466-026-00040-6 · Cited by 48
Self-citationGuo, X., Zhong, W., Chen, Y., Zhang, W., Ren, J., & Gao, A. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.056 · Cited by 42
“For example, upregulated of TET2 induced inflammasomerelated genes Aim2 demethylation associated with increased gene expression [27] while Tet2 repressed transcription of IL-6 and inflammatory via histone deacetylation [30].”
BackgroundResultInfluentialKeratinocyte-derived IκBζ drives psoriasis and associated systemic inflammation
Lorscheid, S., Müller, A., Löffler, J., Resch, C., Bucher, P., Kurschus, F. C., Waisman, A., Schäkel, K., Hailfinger, S., Schulze‐Osthoff, K., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130835 · Cited by 50
“recruit the epigenetic modifier Tet2 and the SWI/SNF nucleosome remodeling complex to target genes, thereby enhancing promoter accessibility (13, 14).”
BackgroundMa, Q., Dasgupta, C., Shen, G., Li, Y., & Zhang, L. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02068-w · Cited by 46
Clonal hematopoiesis: Molecular and clinical implications
Kusne, Y. N., Xie, Z., & Patnaik, M. M. (2022) · Leukemia Research · doi:10.1016/j.leukres.2022.106787 · Cited by 47
Role of ten‐eleven translocation proteins and 5‐hydroxymethylcytosine in hepatocellular carcinoma
Wang, P., Yan, Y., Yu, W., & Zhang, H. (2019) · Cell Proliferation · doi:10.1111/cpr.12626 · Cited by 41
Innate immune responses in RNA viral infection
Xu, Q., Tang, Y., & Huang, G. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0776-7 · Cited by 43
Therapeutic targeting of the inflammasome in myeloid malignancies
Chakraborty, S., Shapiro, L. C., de Oliveira, S., Rivera-Peña, B., Verma, A. K., & Shastri, A. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00547-8 · Cited by 42
“TET2 mutants increase IL-6 production via a decrease in HDAC2 recruitment with a concomitant increase in IL-1β while ASXL1 mutation activates TLR4 signaling and increases NADPH oxidase, and in turn ROS levels [18, 59, 60].”
BackgroundLötscher, F., Seitz, L., Simeunovic, H., Sarbu, A.-C., Porret, N. A., Feldmeyer, L., Borradori, L., Bonadies, N., & Maurer, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.800149 · Cited by 44
Sun, D., Cao, X., & Wang, C. (2018) · Protein & Cell · doi:10.1007/s13238-018-0581-0 · Cited by 39
Self-citationEnzyme Mimicking Based on the Natural Melanin Particles from Human Hair
Hong, S., Zhang, Q., Zheng, D., Zhang, C., Zhang, Y., Ye, J., Cheng, H. L., & Zhang, X. (2019) · iScience · doi:10.1016/j.isci.2019.100778 · Cited by 39
Self-citationTET2 Inhibits PD-L1 Gene Expression in Breast Cancer Cells through Histone Deacetylation
Shen, Y., Liu, L., Wang, M., Xu, B., Lyu, R., Shi, Y. G., & Tan, L. (2021) · Cancers · doi:10.3390/cancers13092207 · Cited by 40
“TET2 has been shown to recruit histone deacetylases (HDAC1/2) to specific gene loci, thereby mediating the transcriptional repression in immune cells [34,35].”
BackgroundZheng, Q., Hou, J., Zhou, Y., Yang, Y., & Cao, X. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502134 · Cited by 42
“The TLR ligands LPS, CpG oligodeoxynucleotide, and polyinosinicpolycytidylic acid [poly(I:C)] were described previously (29).”
BackgroundSelf-citationIL-1 in aging and pathologies of hematopoietic stem cells
Caiado, F., & Manz, M. G. (2024) · Blood · doi:10.1182/blood.2023023105 · Cited by 44
Li, X., Jia, Y., Nan, A., Zhang, N., Zhou, H., Chen, L., Pan, X., Qiu, M., Zhu, J., Zhang, H., et al. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.113749 · Cited by 41
Self-citationCordero, R. Y., Cordero, J. B., Stiemke, A. B., Datta, L. W., Buyske, S. G., Kugathasan, S., McGovern, D. P. B., Brant, S. R., & Simpson, C. L. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac269 · Cited by 42
Molecular dynamics of inflammation resolution: therapeutic implications
Soliman, A. M., Soliman, M. M., Shah, S. S. H., Baig, H. A., Gouda, N. S., Alenezi, B. T., Alenezy, A. K., Hegazy, A. M. S., Jan, M., & Abdalla, E. H. E. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1600149 · Cited by 45
Zhao, H., Li, G., Wang, R., Tao, Z., Ma, Q., Zhang, S., Han, Z., Yan, F., Li, F., Liu, P., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14852 · Cited by 40
“As HDAC2 mediates epigenetic gene silencing (Gonzalez‐Zuniga et al., 2014; Salmon et al., 2012; Zhang et al., 2015), thus, miR‐494‐depressed HDAC2 might lead to the up‐regulation of STAT4 and T‐bet.”
BackgroundWang, X., Wang, J., Yu, Y., Ma, T., Chen, P., Zhou, B., & Tao, R. N. (2017) · Oncotarget · doi:10.18632/oncotarget.18063 · Cited by 41
“The thylcytosine dioxygenase TET2 could promote DNA demethylation to control the production of IFN-γ and IL-17 in autoimmunity [7], and was required to resolve inflammation by recruiting HDAC2 and repressing transcription of IL-6 through histone deacetylation [36].”
BackgroundBewersdorf, J. P., Ardasheva, A., Podoltsev, N. A., Singh, A., Biancon, G., Halene, S., & Zeidan, A. M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100587 · Cited by 40
Brahmi, M., Franceschi, T., Treilleux, I., Pissaloux, D., Ray-Coquard, I. L., Dufresne, A., Vanacker, H., Carbonnaux, M., Méeus, P., Sunyach, M., et al. (2020) · Cancers · doi:10.3390/cancers12092604 · Cited by 39
“TET2 increases the activity of HDAC2 [31], and mutations of this gene have previously been described in other neoplasms such as AML (acute myeloid leukemia) with an unfavorable prognostic value [32].”
BackgroundNasillo, V., Riva, G., Paolini, A., Forghieri, F., Roncati, L., Lusenti, B., Maccaferri, M., Messerotti, A., Pioli, V., Gilioli, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041906 · Cited by 44
A Broad Overview of Signaling in Ph-Negative Classic Myeloproliferative Neoplasms
Guijarro-Hernández, A., & Vizmanos, J. L. (2021) · Cancers · doi:10.3390/cancers13050984 · Cited by 44
Tet2 Controls the Responses of β cells to Inflammation in Autoimmune Diabetes
Rui, J., Deng, S., Perdigoto, A. L., Ponath, G. D., Kursawe, R., Lawlor, N. T., Sumida, T. S., Levine-Ritterman, M., Stitzel, M. L., Pitt, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25367-z · Cited by 35
Tet enzymes are essential for early embryogenesis and completion of embryonic genome activation
Arand, J., Chiang, H. R., Martin, D., Snyder, M. P., Sage, J., Pera, R. A. R., & Wossidlo, M. (2021) · EMBO Reports · doi:10.15252/embr.202153968 · Cited by 40
“…have been shown to also possess non-catalytical functions in recruiting chromatin modifiers and other factors to the genome, which can lead to gene expression changes (Xu et al , 2012; Kaas et al , 2013; Neri et al , 2013; Zhang et al , 2015; Montagner et al , 2016; Montalban-Loro et al , 2019).”
The Role of Ten-Eleven Translocation Proteins in Inflammation
Gerecke, C., Rodrigues, C. E., Homann, T., & Kleuser, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.861351 · Cited by 38
“These findings further demonstrate the general characteristics of TET2 in repressing IL6 transcription in B cells and indicate that TET2 may exert its broad repression of proinflammatory genes in different types of immune cells (96).”
BackgroundInfluentialWu, J., Xu, X., Duan, J., Chai, Y., Song, J., Gong, D., Wang, B., Hu, Y., Han, T., Ding, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45539-x · Cited by 46
Self-citationInflammageing and clonal haematopoiesis interplay and their impact on human disease
Hajishengallis, G., & Chavakis, T. (2026) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00936-y · Cited by 40
Xu, J. M., Xu, X., Wang, B., Ma, Y., Zhang, L., Xu, H., Hu, Y., Wu, J., & Cao, X. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700917114 · Cited by 35
“For example, induction of de novo 5-hydroxymethylation upstream of the Il6 locus by methylcytosine dioxygenase TET2 recruits HDAC2 to specifically inhibit Il6 transcription via histone deacetylation and therefore is critical for termination of the high transcription of Il6 during the late phase of inflammatory respons…”
BackgroundSelf-citationXu, T., Deng, R., Li, X., Zhang, Y., & Gao, M. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.03.015 · Cited by 35
Self-citationUSP38 Couples Histone Ubiquitination and Methylation via KDM5B to Resolve Inflammation
Zhao, Z., Su, Z., Liang, P., Liu, D., Yang, S., Wu, Y., Ma, L., Feng, J., Zhang, X., Wu, C., et al. (2021) · Advanced Science · doi:10.1002/advs.202101964 · Cited by 35
Self-citationImmuno-Modulation of Hematopoietic Stem and Progenitor Cells in Inflammation
Sezaki, M., Hayashi, Y., Wang, Y., Johansson, A., Umemoto, T., & Takizawa, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585367 · Cited by 43
“, found LPS induced Tet2 transcription in macrophages, while Tet2 loss enhanced the secretion of the pro-inflammatory cytokines, IL-6, IL-1b, and TNF and the expression of LPS-induced genes associated with an inflammatory state (143, 144).”
BackgroundWang, Q., & Su, L. (2019) · mBio · doi:10.1128/mbio.01344-19 · Cited by 34
“The TET2-IFITM3 axis in MDMs thus suppresses HIV-1 replication both at the Env processing/virion infectivity step and possibly at the viral entry step in cells previously exposed to Vpr. IFITM3 expression is regulated by DNA methylation at the IFITM3 promoter (46).”
InfluentialThe epigenetic architecture at gene promoters determines cell type-specific LPS tolerance
Klein, K., Frank‐Bertoncelj, M., Karouzakis, E., Gay, R. E., Kolling, C., Ciurea, A., Bostancı, N., Belibasakis, G. N., Lin, L., Distler, O., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.001 · Cited by 35
Reece, A. S., Wang, W., & Hulse, G. K. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.04.011 · Cited by 35
TET1 is an important transcriptional activator of TNFα expression in macrophages
Sun, F., Abreu‐Rodríguez, I., Ye, S., Gay, S., Distler, O., Neidhart, M., & Karouzakis, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218551 · Cited by 34
Circles of Life: linking metabolic and epigenetic cycles to immunity
Lio, C. J., & Huang, S. C. (2020) · Immunology · doi:10.1111/imm.13207 · Cited by 38
Epigenome-metabolome-microbiome axis in health and IBD
Amatullah, H., & Jeffrey, K. L. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.08.005 · Cited by 38
Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis
Miller, P. G., Sperling, A. S., Gibson, C. J., Viswanathan, K., Castellano, C. A., McConkey, M. E., Ceremsak, J. J., Taylor, M. S., Birndt, S., Perner, F., et al. (2020) · Blood · doi:10.1182/blood.2020008206 · Cited by 35
Metadata
- Authors
- Zhang, Q., Zhao, K., Shen, Q., Han, Y., Gu, Y., Li, X., Zhao, D., Liu, Y., Wang, C., Zhang, X., Su, X., Liu, J., Ge, W., Levine, R. L., Li, N., & Cao, X.
- Affiliations
- Second Military Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Cao, Xuetao
- ORCID
- Venue
- Nature
- Published
- 2015-08-19
- Volume
- 525
- Issue
- 7569
- Pages
- 389-393
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4697747
- OpenAlex
- W1171241794
- Cited by
- 807
- References
- 30
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 83 · 2023: 89 · 2022: 93 · 2021: 82 · 2020: 79 · 2019: 85 · 2018: 62 · 2017: 50 · 2016: 43 · 2015: 7
- FWCI
- 23.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA173636, P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TET2, HDAC2, interleukin-6, inflammation resolution, histone deacetylation, transcriptional repression, 5-hydroxymethylcytosine, IκB, lipopolysaccharide, dendritic cells, macrophages, endotoxic shock, DSS-induced colitis
- MeSH terms
- Interleukin-6 Inhibitors, Acetylation, Animals, Chromatin, Colitis, Dendritic Cells, DNA-Binding Proteins, Female, Histones, Humans, Inflammation, Macrophages, Male, Mice, Inbred C57BL, Promoter Regions, Genetic, Proto-Oncogene Proteins, Transcription, Genetic, Down-Regulation, Interleukin-6, DNA Methylation, I-kappa B Proteins, Epigenesis, Genetic, Dioxygenases, Mice, Histone Deacetylase 2, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.